| Pharmacological targeting of the atherogenic dyslipidemia complex: the next frontier in CVD prevention beyond lowering LDL cholesterol C Xiao, S Dash, C Morgantini, RA Hegele, GF Lewis Diabetes 65 (7), 1767-1778, 2016 | 228 | 2016 |
| Anti-inflammatory and antioxidant properties of HDLs are impaired in type 2 diabetes C Morgantini, A Natali, B Boldrini, S Imaizumi, M Navab, AM Fogelman, ... Diabetes 60 (10), 2617-2623, 2011 | 220 | 2011 |
| New insights into the regulation of chylomicron production S Dash, C Xiao, C Morgantini, GF Lewis Annual review of nutrition 35, 265-294, 2015 | 186 | 2015 |
| High-dose resveratrol treatment for 2 weeks inhibits intestinal and hepatic lipoprotein production in overweight/obese men S Dash, C Xiao, C Morgantini, L Szeto, GF Lewis Arteriosclerosis, thrombosis, and vascular biology 33 (12), 2895-2901, 2013 | 120 | 2013 |
| Intranasal insulin suppresses endogenous glucose production in humans compared with placebo in the presence of similar venous insulin concentrations S Dash, C Xiao, C Morgantini, K Koulajian, GF Lewis Diabetes 64 (3), 766-774, 2015 | 117 | 2015 |
| A subset of Kupffer cells regulates metabolism through the expression of CD36 C Blériot, E Barreby, G Dunsmore, R Ballaire, S Chakarov, X Ficht, ... Immunity 54 (9), 2101-2116. e6, 2021 | 114 | 2021 |
| Glucagon-like peptide-2 regulates release of chylomicrons from the intestine S Dash, C Xiao, C Morgantini, PW Connelly, BW Patterson, GF Lewis Gastroenterology 147 (6), 1275-1284. e4, 2014 | 99 | 2014 |
| Liver macrophages regulate systemic metabolism through non-inflammatory factors C Morgantini, J Jager, X Li, L Levi, V Azzimato, A Sulen, E Barreby, C Xu, ... Nature Metabolism 1 (4), 445-459, 2019 | 90 | 2019 |
| Apolipoprotein AI mimetic peptides prevent atherosclerosis development and reduce plaque inflammation in a murine model of diabetes C Morgantini, S Imaizumi, V Grijalva, M Navab, AM Fogelman, ST Reddy Diabetes 59 (12), 3223-3228, 2010 | 82 | 2010 |
| Isolation of Kupffer cells and hepatocytes from a single mouse liver M Aparicio-Vergara, M Tencerova, C Morgantini, E Barreby, M Aouadi Alpha-1 Antitrypsin Deficiency: Methods and Protocols, 161-171, 2017 | 78 | 2017 |
| Sitagliptin, a DPP-4 inhibitor, acutely inhibits intestinal lipoprotein particle secretion in healthy humans C Xiao, S Dash, C Morgantini, BW Patterson, GF Lewis Diabetes 63 (7), 2394-2401, 2014 | 77 | 2014 |
| New and emerging regulators of intestinal lipoprotein secretion C Xiao, S Dash, C Morgantini, GF Lewis Atherosclerosis 233 (2), 608-615, 2014 | 68 | 2014 |
| Novel role of enteral monosaccharides in intestinal lipoprotein production in healthy humans C Xiao, S Dash, C Morgantini, GF Lewis Arteriosclerosis, thrombosis, and vascular biology 33 (5), 1056-1062, 2013 | 62 | 2013 |
| Gut peptides are novel regulators of intestinal lipoprotein secretion: experimental and pharmacological manipulation of lipoprotein metabolism C Xiao, S Dash, C Morgantini, K Adeli, GF Lewis Diabetes 64 (7), 2310-2318, 2015 | 60 | 2015 |
| Accelerated phosphatidylcholine turnover in macrophages promotes adipose tissue inflammation in obesity K Petkevicius, S Virtue, G Bidault, B Jenkins, C Çubuk, C Morgantini, ... Elife 8, e47990, 2019 | 56 | 2019 |
| HDL lipid composition is profoundly altered in patients with type 2 diabetes and atherosclerotic vascular disease C Morgantini, D Meriwether, S Baldi, E Venturi, S Pinnola, AC Wagner, ... Nutrition, Metabolism and Cardiovascular Diseases 24 (6), 594-599, 2014 | 54 | 2014 |
| Dysfunctional high-density lipoprotein and the potential of apolipoprotein A-1 mimetic peptides to normalize the composition and function of lipoproteins S Imaizumi, M Navab, C Morgantini, C Charles-Schoeman, F Su, F Gao, ... Circulation journal 75 (7), 1533-1538, 2011 | 50 | 2011 |
| Liver macrophages inhibit the endogenous antioxidant response in obesity-associated insulin resistance V Azzimato, J Jager, P Chen, C Morgantini, L Levi, E Barreby, A Sulen, ... Science translational medicine 12 (532), eaaw9709, 2020 | 49 | 2020 |
| Hepatic miR-144 drives fumarase activity preventing NRF2 activation during obesity V Azzimato, P Chen, E Barreby, C Morgantini, L Levi, A Vankova, J Jager, ... Gastroenterology 161 (6), 1982-1997. e11, 2021 | 36 | 2021 |
| Intravenous glucose acutely stimulates intestinal lipoprotein secretion in healthy humans C Xiao, S Dash, C Morgantini, GF Lewis Arteriosclerosis, Thrombosis, and Vascular Biology 36 (7), 1457-1463, 2016 | 35 | 2016 |
